This service is designed to assist Australian biotechnology and medical device companies, particularly startups, in developing products that meet Chinese regulatory requirements and market demands. The service encompasses various stages, including product research and development, manufacturing, registration, and sales. Our team of expert consultants, comprising top Australian academicians, seasoned translational medical scientists, and Chinese regulatory registration experts, provides your company with clinical development strategy guidance tailored to unmet clinical needs and regulatory registration requirements. ​

Our expertise enables us to assist Australian companies in rapidly introducing their products to the Chinese market, reducing product development costs and risks in China, and enhancing product competitiveness in the Chinese market.